News by subject: Share Issue

InVivo Therapeutics Holdings Corp. , a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that it has entered into a definitive agreement with a single...

Amylyx Pharmaceuticals, Inc. ("Amylyx") today announced the pricing of an upsized underwritten public offering of 6,693,750 shares of its common stock at a public offering price of $32.00 per share. All of the shares of common stock are being...

Blue Apron today announced that it has completed its previously announced at-the-market equity offering program under which it sold shares of its Class A common stock for aggregate gross proceeds to the company of approximately $15 million. A total...

Amylyx Pharmaceuticals, Inc. ("Amylyx") today announced the launch of an underwritten public offering of 6,000,000 shares of common stock pursuant to a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission ("SEC")....

Cian PLC ("Cian", the "Group" or the "Company"), a leading online real estate classifieds platform in Russia, announces the results of 2022 Annual General Meeting (the "AGM") held on September 30, 2022. As reflected in the voting results below, all...

Aurinia Pharmaceuticals Inc. (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, announced that the Company's Compensation Committee granted 4 new employees...

Adicet Bio, Inc. , a clinical-stage biotechnology company discovering and developing allogeneic gamma delta CAR T cell therapies for cancer, today announced it granted inducement awards on September 30, 2022 (the "Grant Date") under Adicet's 2022...

voxeljet AG (WKN: A2QBGM / ISIN: US92912L2060) (the "Company", or "voxeljet"), a leading provider of high-speed, large-format 3D printers and on-demand parts services to industrial and commercial customers, today announced that it has entered into...

voxeljet AG (WKN: A2QBGM / ISIN: US92912L2060) (the "Company", or "voxeljet") management board today approved, with the consent of the supervisory board, an increase in the company's registered share capital against cash contributions, under...

Gamida Cell Ltd. , the global leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, today announced the launch of a follow-on public offering of its ordinary shares. In...

United Natural Foods, Inc. (the "Company" or "UNFI") today reported financial results for the fourth quarter (13 weeks) and fiscal year (52 weeks) ended July 30, 2022. Fiscal 2022 Full Year Highlights Net sales increased 7.3% to $28.9 billion...

Allianz Investment Management LLC (AllianzIM), a wholly-owned subsidiary of Allianz Life Insurance Company of North America (Allianz Life®), announced a ticker symbol change for eight existing AllianzIM Buffered Outcome ETFs effective on October 31,...

Vroom, Inc. , a leading e-commerce platform for buying and selling used vehicles, today reported that on September 22, 2022, the Compensation Committee of Vroom's Board of Directors approved the grant of inducement restricted stock unit awards...

Geron Corporation today reported that it has granted non-statutory stock options to purchase an aggregate of 901,950 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company....

Loop Media, Inc. ("Loop Media") , a leading multi-channel streaming platform that provides curated music video and branded entertainment channels for businesses and consumers, today announced the pricing of an underwritten public offering of...

WeCommerce Holdings Ltd. ("WeCommerce" or the "Company") today announced that the TSX Venture Exchange (the "Exchange") has accepted the Company's Notice of Intention to renew a normal course issuer bid ("NCIB"). Pursuant to the NCIB, WeCommerce...

Alpine Immune Sciences, Inc. , a clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today announced the pricing of its underwritten public offering of 13,606,000...

Aditxt, Inc., (the "Company" or "Aditxt"), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, today announced the closing of its previously announced public offering of...

Know Labs, Inc. , an emerging developer of non-invasive medical diagnostic technology, today announced the closing of its underwritten public offering of 4,140,000 shares of its Common Stock at a public offering price of $2.00 per share, which...

(This notice has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.) Company name: Rays Company (Hong Kong)...

Ingram Micro Inc. announced that Ingram Micro Holding Corporation has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of its...

Aditxt, Inc., (the "Company" or "Aditxt"), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, today announced the pricing of a public offering of 3,333,333 shares of its...

Airgain, Inc. , a global provider of wireless connectivity solutions, including embedded components, external antennas, and integrated systems, today announced that it has granted inducement awards to 3 new non-executive employees who recently joined...

Spire Global, Inc. ("Spire" or "the Company"), a leading global provider of space-based data, analytics and space services, today announced that it has filed an S-3 shelf registration statement with the Securities and Exchange Commission ("the...

PotlatchDeltic Corporation ("PotlatchDeltic") announced today the successful completion of the previously announced merger of CatchMark Timber Trust, Inc. ("CatchMark") with PotlatchDeltic in an all-stock transaction, creating a leading integrated...

Teucrium Trading, LLC, the Sponsor of agricultural futures-based ETFs, today announced that the 2021 Schedule K-3(s) reflecting items of international tax relevance are available online. Unitholders requiring this information may access their...

Savara Inc. , a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to three new employees. On September 13, 2022, the Compensation Committee of Savara's Board of Directors...

NanoVibronix, Inc. ("Nano" or the "Company"), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that its Board of Directors declared a dividend of one...

Edgewise Therapeutics, Inc., today announced that it intends to offer and sell shares of its common stock in an underwritten public offering of $100 million of its common stock. In addition, Edgewise Therapeutics intends to grant the underwriters a...

Securitize, a leading digital asset securities firm, today announced the launch of a fund tokenizing an interest in KKR's Health Care Strategic Growth Fund II ("HCSG II") on the Avalanche public blockchain. This is a major step toward making...

Innovative Solutions and Support, Inc. ("IS&S" or the "Company") today announced that its Board of Directors (the "Board") has adopted a stockholder rights plan and declared a dividend distribution of one preferred share purchase right on each...

Alnylam Pharmaceuticals, Inc. ("Alnylam") , the leading RNAi therapeutics company, announced today that it has commenced a private offering of $900 million aggregate principal amount of convertible senior notes due 2027 (the "notes") to persons...

Arcus Biosciences, Inc. , an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that the Compensation Committee of the Company's Board of Directors granted ten new employees options to...

DLQ, Inc., a provider of digital consumer acquisition solutions ("DLQ"), and a wholly-owned subsidiary of Logiq, Inc. , today announced it has entered into a definitive merger agreement ("Merger Agreement") for a business combination whereby it will...

Global Business Travel Group, Inc. (the "Company" or "GBTG") , the world's leading B2B travel platform, today announced that it has commenced an exchange offer (the "Offer") and consent solicitation (the "Consent Solicitation") relating to its...

UroGen Pharma Ltd. a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement restricted stock units ("RSUs") to 10 new employees in...

Horizon Therapeutics plc today announced that its Board of Directors authorized the repurchase of up to $500 million of the Company's ordinary shares. "This share repurchase program reinforces the confidence we have in our strategy and our...

BlackRock Corporate High Yield Fund, Inc. (the "Fund") today announced that its Board of Directors (the "Board") has approved the terms of the issuance of transferable rights ("Rights") to the holders of shares of the Fund's common stock (par value...

Regulatory News: Nanobiotix (Paris:NANO) : Market: Euronext Paris / Nasdaq Euronext Compartment: B ISIN code: FR0011341205 Nasdaq: NBTX Bloomberg: NANO:FP Reuters: NANO.PA Website: www.nanobiotix.com Date Number of Shares Outstanding...

Olo Inc. , a leading open SaaS platform for restaurants that enables hospitality at every touchpoint, today announced that its board of directors authorized a share repurchase program for up to $100,000,000 of the Company's Class A common stock. The...

Regulatory News: In accordance with resolutions 18 and 19 approved by the Shareholders' Meeting on July 21, 20221, the Board of Directors of Rémy Cointreau (Paris:RCO) decided to authorize the Group's Chief Executive Officer to implement a share...

SMART Global Holdings, Inc. ("SGH") , today announced that the independent Compensation Committee of the Board of Directors of SGH has approved the grant, as of August 29, 2022, of restricted share units ("RSUs") with respect to an aggregate of...

Puma Biotechnology, Inc. , a biopharmaceutical company, announced that on September 1, 2022, the Compensation Committee of Puma's Board of Directors approved the grant of inducement restricted stock unit awards covering 18,750 shares of Puma common...

Kezar Life Sciences, Inc., , a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that the Compensation Committee of the company's Board of Directors...

Biocept, Inc. , a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purchase an aggregate of 89,550 shares of its common stock to 12 new employees. The inducement...

PotlatchDeltic Corporation announced today that its Board of Directors approved a new $200 million share repurchase program. This program replaces the existing $100 million share repurchase program authorized in August 2018. "Returning cash to our...

Cybin Inc. (NEO:CYBN) ("Cybin" or the "Company"), a biotechnology company focused on progressing Psychedelics to Therapeuticstm, is pleased to announce that Adelia Therapeutics Inc. ("Adelia"), a wholly-controlled subsidiary of Cybin, has achieved...

Lightning eMotors, Inc. , a leading provider of zero emission medium-duty commercial vehicles and electric vehicle technology for fleets, today announced that the Company has entered into a purchase agreement and registration rights agreement...

Coyuchi, the first organic luxury home goods brand for sustainable living, announces today the opportunity for the general public to invest through a Regulation A+ offering for the first time in its 30+ year history. This Regulation A+ offering has...

Navidea Biopharmaceuticals, Inc. ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced today the preliminary results of its rights offering which expired at 5:00...